Milvexian: Data readout from P3 LIBREXIA-STROKE trial (NCT05702034) for secondary stroke prevention in 2026 (Bristol-Myers Squibb) - Jul 31, 2025 - Q2 2025 Results: Data readout from P3 LIBREXIA-ACS trial (NCT05754957) for acute coronary syndrome in 2026
P3 data • Acute Coronary Syndrome • Cardiovascular
|